New pages
- 11:40, 14 October 2019 T-cell prolymphocytic leukemia (hist) [1,500 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#de2d26"|'''Section editor''' |- |s...")
- 21:40, 11 October 2019 Value frameworks (hist) [3,106 bytes] Jwarner (talk | contribs) (Created page with " =Introduction= Several leading hematology/oncology societies and organizations have put forth value frameworks. Conceptually, these are approaches which are intended to combi...")
- 21:31, 1 October 2019 Trastuzumab-qyyp (Trazimera) (hist) [2,117 bytes] Jwarner (talk | contribs) (Created page with "'''Note: this is a biosimilar. The information below is reproduced from the Trastuzumab (Herceptin) page, except for the details of FDA indication.''' ==General informatio...")
- 21:30, 1 October 2019 Trastuzumab-dttb (Ontruzant) (hist) [2,117 bytes] Jwarner (talk | contribs) (Created page with "'''Note: this is a biosimilar. The information below is reproduced from the Trastuzumab (Herceptin) page, except for the details of FDA indication.''' ==General informatio...")
- 21:29, 1 October 2019 Trastuzumab-anns (Kanjinti) (hist) [2,116 bytes] Jwarner (talk | contribs) (Created page with "'''Note: this is a biosimilar. The information below is reproduced from the Trastuzumab (Herceptin) page, except for the details of FDA indication.''' ==General informatio...")
- 21:23, 1 October 2019 Rituximab-pvvr (Ruxience) (hist) [5,359 bytes] Jwarner (talk | contribs) (Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Rituximab (Rituxan) page, except for the details of FDA indication.''' ==General...")
- 09:45, 4 September 2019 Allogeneic stem cells (hist) [192 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: Hematopoietic stem/progenitor cells <br>Route: IV <br>Extravasation: No information Category:Cellular therapy Category:Intraven...")
- 11:19, 17 August 2019 Fedratinib (Inrebic) (hist) [1,736 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/jak2-inhibitor-tg101348 NCI Drug Dictionary]: An orally bioa...")
- 18:27, 16 August 2019 Dartmouth-Hitchcock Medical Center Hematology Oncology Fellowship (hist) [2,778 bytes] Ndhawan (talk | contribs) (Created page with "'''<big>For information about other programs, please visit the Hematology Oncology Fellowship Programs Directory.</big>''' '''People affiliated with this program are cord...")
- 18:17, 16 August 2019 Georgetown University Hospital Hematology Oncology Fellowship (hist) [2,566 bytes] Ndhawan (talk | contribs) (Created page with "'''<big>For information about other programs, please visit the Hematology Oncology Fellowship Programs Directory.</big>''' '''People affiliated with this program are cord...")
- 22:09, 11 August 2019 Travel award (hist) [3,340 bytes] Warner-admin (talk | contribs) (Created page with "<big>'''Due to a generous grant from Vanderbilt University, we are able to offer a small number of travel awards to qualified applicants. We intend to support one to two $500...")
- 09:50, 5 August 2019 Trastuzumab and hyaluronidase (Herceptin Hylecta) (hist) [1,434 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/797111 NCI Drug Dictionary]: A ready-to-use combination of trastuzumab, a re...")
- 14:33, 3 August 2019 Meperidine (Demerol) (hist) [280 bytes] Jwarner (talk | contribs) (Created page with "An opiate usually used for the side effect of treating or preventing rigors. Category:Drugs Category:Oral medications Category:Intravenous medications Category:...")
- 14:31, 3 August 2019 Ascorbic acid (Vitamin C) (hist) [88 bytes] Jwarner (talk | contribs) (Created page with "Vitamin C Category:Drugs Category:Oral medications Category:OTC medications")
- 14:30, 3 August 2019 Hydroxyzine (Atarax) (hist) [1,061 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: first-generation antihistamine. <br>Route: PO <br>Extravasation: unknown For conciseness and simplicity, HemOnc.org currently will fo...")
- 14:28, 3 August 2019 Clonazepam (Klonopin) (hist) [211 bytes] Jwarner (talk | contribs) (Created page with "Benzodiazepine. No known antineoplastic properties. ==Also known as== *'''Brand name:''' Klonopin Category:Drugs Category:Oral medications [[Category:Benzodiazepine]...")
- 21:40, 28 July 2019 Emapalumab (Gamifant) (hist) [1,900 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/anti-interferon-gamma-monoclonal-antibody-ni-0501 NCI Drug D...")
- 11:38, 25 July 2019 Benralizumab (Fasenra) (hist) [547 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: A humanized monoclonal antibody targeting interleukin-5 (IL-5). ==Diseases for which it is used== *Hypereosinophilic syndrome (HES...")
- 20:21, 17 July 2019 Basics of Pain Management (hist) [696 bytes] Ndhawan (talk | contribs) (Created page with "WHO's Cancer Pain Ladder for Adults thumb|WHO's cancer pain ladder “WHO's Cancer Pain Ladder for Adults.” World Health Organization, World Healt...")
